Cesar V Borlongan Selected Research

Kainic Acid (Kainate)

1/2017	Extracellular HMGB1 Modulates Glutamate Metabolism Associated with Kainic Acid-Induced Epilepsy-Like Hyperactivity in Primary Rat Neural Cells.
4/2016	Kainic Acid-Induced Golgi Complex Fragmentation/Dispersal Shifts the Proteolysis of Reelin in Primary Rat Neuronal Cells: An In Vitro Model of Early Stage Epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cesar V Borlongan Research Topics

Disease

125	Stroke (Strokes) 04/2024 - 01/2003
42	Ischemic Stroke 04/2024 - 02/2004
31	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2023 - 07/2009
28	Inflammation (Inflammations) 02/2024 - 02/2006
28	Nervous System Diseases (Neurological Disorders) 10/2022 - 01/2005
21	Parkinson Disease (Parkinson's Disease) 06/2023 - 07/2004
19	Ischemia 10/2023 - 02/2004
18	Infarction (Infarctions) 11/2023 - 04/2004
16	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2023 - 04/2004
13	Neuroinflammatory Diseases 07/2020 - 01/2014
12	Brain Injuries (Brain Injury) 01/2020 - 04/2004
9	Brain Ischemia (Cerebral Ischemia) 04/2024 - 02/2004
8	Cerebral Infarction 05/2018 - 02/2004
7	Epilepsy (Aura) 01/2023 - 04/2016
7	Hypothermia 11/2019 - 01/2012
6	Brain Diseases (Brain Disorder) 10/2021 - 04/2004
6	Neoplasms (Cancer) 01/2019 - 02/2005
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2004
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023 - 01/2011
5	Wounds and Injuries (Trauma) 09/2023 - 02/2005
5	Huntington Disease (Huntington's Disease) 01/2022 - 01/2003
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2011
5	Myocardial Infarction 07/2013 - 01/2004
4	Cognitive Dysfunction 01/2020 - 01/2017
3	Hypoxia (Hypoxemia) 09/2023 - 02/2004
3	Edema (Dropsy) 09/2023 - 06/2018
3	Reperfusion Injury 12/2022 - 06/2009
3	Multiple Sclerosis 01/2021 - 04/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 06/2020 - 07/2018
3	Central Nervous System Diseases (CNS Diseases) 07/2019 - 02/2004
3	Fetal Alcohol Spectrum Disorders 01/2019 - 10/2014
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 01/2013
2	Dysbiosis 01/2023 - 01/2021
2	COVID-19 10/2021 - 01/2021
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 11/2007
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021 - 01/2014
2	Vision Disorders (Hemeralopia) 01/2020 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2019 - 01/2018
2	Demyelinating Diseases (Demyelinating Disease) 10/2018 - 04/2014
2	Memory Disorders (Memory Loss) 01/2018 - 05/2015
2	Hemorrhage 02/2015 - 10/2010
2	Diseases Newborn Infant 06/2014 - 03/2010
2	Cerebral Palsy (Spastic Diplegia) 01/2014 - 12/2013
2	Teratocarcinoma 07/2008 - 02/2005

Drug/Important Bio-Agent (IBA)

22	Therapeutic UsesIBA 05/2023 - 12/2009
17	Neuroprotective AgentsIBA 01/2021 - 04/2004
15	Oxygen (Dioxygen)IBA 09/2023 - 10/2009
13	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2009
11	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2022 - 01/2009
11	Nerve Growth Factors (Neurotrophins)IBA 01/2018 - 07/2004
10	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2014
7	CytokinesIBA 01/2023 - 01/2014
7	Opioid Analgesics (Opioids)IBA 01/2018 - 06/2009
6	Retinaldehyde (Retinal)IBA 07/2020 - 04/2013
6	salicylhydroxamic acid (SHAM)IBA 01/2016 - 02/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 12/2013
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
5	EnzymesIBA 01/2016 - 10/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2020
4	Peptides (Polypeptides)IBA 02/2021 - 02/2006
4	Alprostadil (Muse)FDA LinkGeneric 01/2021 - 01/2018
4	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 12/2018 - 06/2009
4	LigandsIBA 01/2018 - 01/2012
4	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2018 - 01/2012
4	Mannitol (Osmitrol)FDA LinkGeneric 01/2016 - 10/2004
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023 - 01/2018
3	AntioxidantsIBA 02/2021 - 01/2016
3	MelatoninIBA 07/2020 - 04/2013
3	erucylphosphocholineIBA 01/2019 - 01/2012
3	Caspase 3 (Caspase-3)IBA 10/2018 - 01/2012
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2009
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 05/2011
3	Hematoxylin (Haematoxylon)IBA 09/2015 - 01/2012
3	Eosine Yellowish-(YS) (Eosin)IBA 09/2015 - 01/2012
3	Opioid Peptides (Opioid Peptide)IBA 08/2013 - 06/2009
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 12/2010 - 05/2007
3	Minocycline (Cyclops)FDA LinkGeneric 10/2009 - 04/2004
3	Kallikreins (Kallikrein)IBA 04/2006 - 02/2004
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2017
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2019 - 02/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2019 - 09/2015
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 10/2016
2	Kainic Acid (Kainate)IBA 01/2017 - 04/2016
2	NestinIBA 03/2016 - 01/2012
2	SynucleinsIBA 05/2015 - 10/2013
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2012 - 03/2009
2	Tetracycline (Achromycin)FDA LinkGeneric 10/2009 - 04/2004
2	KininsIBA 04/2006 - 02/2004

Therapy/Procedure

120	Therapeutics 04/2024 - 01/2003
54	Transplantation 11/2023 - 01/2003
26	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021 - 05/2008
17	Stem Cell Transplantation 04/2024 - 01/2012
15	Cell Transplantation 01/2021 - 02/2004
6	Hyperbaric Oxygenation 09/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 07/2020 - 04/2014
3	Investigational Therapies (Experimental Therapy) 03/2020 - 10/2015
2	Lasers (Laser) 06/2020 - 01/2020
2	Injections 04/2017 - 01/2011